Today on Outsourcing-Pharma.com   Wyeth warns of job cut woes AstraZeneca forms cancer collaboration Singapore's biomedical manufacturing down a third in December MDS Pharma opens large Phase I unit UAE's first pharma 3PL provider springs up

Related Industry News   Acquisitions pay off for Novozymes ingredients in 2007 Ventana gives in to Roche merger following increased offer Teva jumps on biologics bandwagon with $400m buy Roche ramps up biotech

Breaking News on Outsourcing Pharma
Daily  Monday 28 January 2008		Forward to a colleague

	Company Profile Introducing Catalent Pharma Solutions Catalent Pharma Solutions is the leading provider of advanced technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies in nearly 100 countries... Click Here Access Full Stories Wyeth warns of job cut woes Wyeth is the latest big pharma firm to warn that major job cuts are on the cards, amidst a series of drug approval setbacks and generic erosion on profits... Read AstraZeneca forms cancer collaboration AstraZeneca has announced a new collaboration with the University of Texas' MD Anderson Cancer Center as it steps up its reliance on external partners... Read Singapore's biomedical manufacturing down a third in December Another sharp decline in biomedical production saw overall manufacturing output in Singapore fall for the second month running in December, prompting fears that the heavily trade-reliant economy could buckle under... Read MDS Pharma opens large Phase I unit MDS Pharma Services has opened its new Phase I clinic in Arizona - the largest of its kind on the US west coast... Read UAE's first pharma 3PL provider springs up A new enterprise in the United Arab Emirates (UAE) is establishing itself as the region's first pharmaceutical-focused third party logistics (3PL) provider... Read
	All News Headlines for: January | December | November
	Sponsored Link DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here
	Related Industry News Acquisitions pay off for Novozymes ingredients in 2007 The small but fast-growing biopharmaceutical ingredients (BPI) business of Denmark's Novozymes, the leading manufacturer of industrial enzymes worldwide, delivered a strong performance in 2007, with sales rising... Read Ventana gives in to Roche merger following increased offer After seven months of offers, refusals and heated exchanges, it seems an increased offer from Roche has finally persuaded the powers that be at Ventana to sell up... Read Teva jumps on biologics bandwagon with $400m buy Israeli generics behemoth Teva is following the market and banking on the promise of biologics with its purchase of Human Genome Sciences biotech spin-off, CoGenesys... Read Roche ramps up biotech Roche has announced major investments at three of its European sites, continuing its drive to strengthen its position in the biopharmaceutical market... Read Weekly comment UK Government plans will stifle innovation, say biotechs New UK Government proposals to scrap Capital Gains Tax (CGT) relief will stifle life science innovation, according to a group of biotech small and medium enterprises (SMEs). Read Previous Headlines Lonza looks to the future as it reveals 2007 profit hike Lonza has revealed a profit hike for the full year of 2007, reflecting the fruit of its "revised growth strategies" across its business units, said the firm, which also announced its "innovations" for future growth... Read Invetech commits to tackle US market Australia-based Invetech has committed itself to tackling the US market, opening up its first facility in the country - home of the world's largest drug industry... Read Contract manufacturing news in brief KBI Biopharma, Helix BioMedix and Azopharma have all recently announced new contract manufacturing news... Read Lilly lashes out at clinical data suppression suggestion Eli Lilly has released a statement strongly objecting to implications made in a New York Times article that it has suppressed results of negative clinical trials... Read New HPAPI plant for Novasep French firm Novasep has significantly upped its capacity with a new high potency active pharmaceutical ingredient (HPAPI) plant at its facility in Le Mans, France... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Information - brochures, Web centers Introducing Catalent Pharma Solutions - Company Profile Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com